Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]
Phase 2 randomized trial evaluating oral AB1010 in adults with moderate to severe chronic plaque psoriasis completed.
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS [Phase 2]
A Phase 2 safety study completed evaluating potential adrenal suppression with maximal use treatment DSXS in psoriasis patients; results pos…
-
FDA approval · 2018-11-29FDA Approved: FLUOCINONIDE — Original Application (Encube Ethicals, Inc.)
The FDA approved Encube Ethicals, Inc.'s fluocinonide topical solution 0.05% as a generic topical corticosteroid for inflammatory and prurit…
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests [Phase 4]
Phase 4 trial assessing safety and sensitizing potential of HAT1 topical products using skin sensitivity patch tests in healthy and atopic d…
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial update for VTP-43742 in healthy volunteers and patients with psoriasis, completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating efficacy and safety of 122-0551 in subjects with plaque psoriasis has completed with results posted.
-
FDA approval · 2018-10-16FDA Approved: FLUOCINONIDE — Original Application (Encube Ethicals, Inc.)
FDA approved Fluocinonide under Encube Ethicals, Inc.'s Original Application (ANDA 211410), establishing regulatory approval for this topica…
-
FDA approval · 2018-10-12FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Cosette Pharmaceuticals, Inc.)
The FDA approved Cosette Pharmaceuticals' original application for a generic Betamethasone Dipropionate topical product.
-
FDA approval · 2018-10-04FDA Approved: CLOBETASOL PROPIONATE — Original Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved CLOBETASOL PROPIONATE as an original-application generic topical product. The approval holder is Taro Pharmaceuticals U.S.A., I…
-
FDA approval · 2018-09-28FDA Approved: DESOXIMETASONE — Original Application (Viona Pharmaceuticals Inc)
The FDA approved Viona Pharmaceuticals Inc.'s desoximetasone topical product as an original application, providing a generic version of the …
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis [Phase 3]
Phase 3 trial update for M923 in combination with Humira in chronic plaque-type psoriasis; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-06Clinical Trial Update: Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis [Phase 3]
Phase 3 efficacy and safety results for guselkumab in adults with moderate-to-severe plaque psoriasis have been completed and results posted…
-
FDA approval · 2018-08-21FDA Approved: FLUOCINONIDE CREAM — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved a generic fluocinonide cream from Amneal Pharmaceuticals NY LLC (ANDA 210554).
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate [Phase 4]
Phase 4 clinical trial evaluating optimization of psoriasis treatment using etanercept in combination with methotrexate; completed.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) [Phase 3]
Phase 3 trial evaluating two dose levels of certolizumab pegol for plaque psoriasis; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) [Phase 3]
Phase 3 trial evaluating two doses of certolizumab pegol for plaque psoriasis has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin [Phase 4]
Phase 4 trial assessing capsaicin effects on cutaneous small nerve fibers in psoriatic skin was terminated.
-
CLINICAL_TRIALS withdrawal · 2018-07-19Clinical Trial Update: Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis [Phase 4]
A Phase 4 psoriasis trial evaluating the combination of steroids with dithranol and narrow-band UVB has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO) [Phase 3]
Phase 3 trial assessing certolizumab pegol versus active comparator and placebo in plaque psoriasis; study completed with results posted in …
-
FDA approval · 2018-07-17FDA Approved: FLUOCINONIDE — Original Application (Zydus Lifesciences Limited)
FDA approved the fluocinonide topical product from Zydus Lifesciences Limited via an Original Application, marking the first generic entry f…
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Ovarian Reserve in Patients With Psoriasis
A completed clinical trial evaluated ovarian reserve via anti-Müllerian hormone in patients with psoriasis.
-
CLINICAL_TRIALS research · 2018-07-05Clinical Trial Update: Prevalence of Sleep Disturbances in Psoriasis
A completed clinical trial evaluating how prevalent sleep disturbances are among individuals with psoriasis.
-
CLINICAL_TRIALS research · 2018-07-05Clinical Trial Update: A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers [Phase 1]
This Phase 1 study assesses the effect of food on the pharmacokinetics of Hemay005 in healthy volunteers as part of psoriasis drug developme…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects [Phase 1]
Phase 1 safety and pharmacokinetics study of Hemay005, intended for psoriasis, in healthy male subjects has been completed.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Evaluating Treatment Resistant Dermatitis TaroIIR [Phase 4]
Phase 4 clinical trial update for treatment-resistant dermatitis (Atopic Dermatitis and Psoriasis) completed with results posted in 2018.